The effect of mydriatics on posterior synechia after combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation

Retina. 2009 Sep;29(8):1150-4. doi: 10.1097/IAE.0b013e3181a3b85c.

Abstract

Purpose: To compare short-acting mydriatics versus long-acting mydriatics and to assess their effect on postoperative frequency and severity of posterior synechia after combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation.

Methods: We retrospectively reviewed the records of 69 eyes of 69 patients who received a combined operation by the same surgeon for rhegmatogenous retinal detachment and cataracts. The mean follow-up period in both groups was 43 weeks. The frequency and severity of posterior synechia were analyzed at baseline and over a 6-month follow-up period.

Results: Of the 69 eyes, 29.7% (11 of 37) in the long-acting mydriatic group versus 9.4% (3 of 32) in the short-acting mydriatic group had developed posterior synechia. The difference was statistically significant (P = 0.036). Additionally, when the severity of posterior synechia was measured in hour units, there was a statistically significant difference in severity between the 2 groups (long-acting mydriatic group, 0.76 +/- 1.52 hours; short-acting mydriatic group, 0.13 +/- 0.42 hours; P = 0.020).

Conclusion: The frequency and severity of posterior synechia after a combined operation may be reduced by the use of a short-acting mydriatic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Atropine / therapeutic use
  • Female
  • Humans
  • Iris / physiopathology
  • Lens Implantation, Intraocular*
  • Lens, Crystalline / physiopathology
  • Male
  • Middle Aged
  • Mydriatics / therapeutic use*
  • Phacoemulsification*
  • Phenylephrine / therapeutic use
  • Postoperative Complications*
  • Retinal Detachment / surgery
  • Retrospective Studies
  • Tissue Adhesions / drug therapy*
  • Tissue Adhesions / physiopathology
  • Treatment Outcome
  • Tropicamide / therapeutic use
  • Vitrectomy*

Substances

  • Mydriatics
  • Phenylephrine
  • Atropine
  • Tropicamide